Staphylococcal SSL5 binding to human leukemia cells inhibits cell adhesion to endothelial cells and platelets

Cellular Oncology

Volumn 32, Issue 1-2, 2010, Pages 1-10

  Walenkamp, Annemiek M E ^a,b   Bestebroer, Jovanka ^b   Boer, Ingrid G J ^b   Kruizinga, Roeline ^a   Verheul, Henk M ^c   Van Strijp, Jos A G ^b   De Haas, Carla J C ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

HL 60; Leukemia; PSGL 1; SSL5; Staphylococcus aureus

Indexed keywords

BACTERIAL PROTEIN; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; SIALYL LEWIS X ANTIGEN; STAPHYLOCOCCAL SUPERANTIGEN LIKE 5; SUPERANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL ADHESION; CELL INTERACTION; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; THROMBOCYTE;

BACTERIAL PROTEINS; BLOOD PLATELETS; CELL ADHESION; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIAL CELLS; HL-60 CELLS; HUMANS; LEUKEMIA; NEUTROPHILS; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 77749258142     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2009-0486     Document Type: Article

References (47)

1. S. Aigner, C.L. Ramos, A. Hafezi-Moghadam et al., CD24 mediates rolling of breast carcinoma cells on P-selectin, FA S E B J. 12 (1998), 1241-1251.
2. M. Anostario Jr., S.H. Li and K.S. Huang, A ligand binding assay for E-selectin, Anal. Biochem. 221 (1994), 317-322.
3. V.L. Arcus, R. Langley, T. Proft et al., The three-dimensional structure of a superantigen-like protein, SET3, from a patho-genicity island of the Staphylococcus aureus genome, J. Biol. Chem. 277 (2002), 32274-32281.
4. A. Aruffo, M.T. Dietsch, H. Wan et al., Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines, Proc. Natl. Acad. Sci. USA 89 (1992), 2292-2296.
5. H.M. Baker, I. Basu, M.C. Chung et al., Crystal structures of the staphylococcal toxin SSL5 in complex with sialyl Lewis X reveal a conserved binding site that shares common features with viral and bacterial sialic acid binding proteins, J. Mol. Biol. 374 (2007), 1298-1308.
6. J. Bestebroer, M.J. Poppelier, L.H. Ulfman et al., Staphylococ-cal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling, Blood 109 (2007), 2936-2943.
7. J. Bestebroer, K.P. van Kessel, H. Azouagh et al., Staphylo-coccal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins, Blood 113 (2009), 328-337.
8. L. Borsig, R. Wong, J. Feramisco et al., Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis, Proc. Natl. Acad. Sci. USA 98 (2001), 3352-3357.
9. J.A. Chabalgoity, G. Dougan, P. Mastroeni et al., Live bacteria as the basis for immunotherapies against cancer, Exp. Rev. Vaccines 1 (2002), 495-505.
10. M. Chen and J.G. Geng, P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis, Arch. Immunol. Ther. Exp. (Warsz.) 54 (2006), 75-84.
11. M.C. Chung, B.D. Wines, H. Baker et al., The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition, Mol. Microbiol. 66 (2007), 1342-1355.
12. R. Dardik, Y. Kaufmann, N. Savion et al., Platelets mediate tumor cell adhesion to the subendothelium under flow conditions: involvement of platelet GPIIb-IIIa and tumor cell alpha(v) in-tegrins, Int. J. Cancer 70 (1997), 201-207.
13. C.J. de Haas, K.E. Veldkamp, A. Peschel et al., Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiin-flammatory agent, J. Exp. Med. 199 (2004), 687-695.
14. C.J. Dimitroff, L. Descheny, N. Trujillo et al., Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells, Cancer Res. 65 (2005), 5750-5760.
15. C.J. Dimitroff, J.Y. Lee, R.C. Fuhlbrigge et al., A distinct gly-coform of CD44 is an L-selectin ligand on human hematopoi-etic cells, Proc. Natl. Acad. Sci. USA 97 (2000), 13841-13846.
16. E. Gorelik, U. Galili and A. Raz, On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis, Cancer Metast. Rev. 20 (2001), 245-277.
17. D.A. Guyer, K.L. Moore, E.B. Lynam et al., P-selectin gly-coprotein ligand-1 (PSGL-1) is a ligand for L-selectin in neu-trophil aggregation, Blood 88 (1996), 2415-2421.
18. W.D. Hanley, S.L. Napier, M.M. Burdick et al., Variant iso-forms of CD44 are P-and L-selectin ligands on colon carcinoma cells, FA S E B J. 20 (2006), 337-339.
19. J.A. Heit, M.D. Silverstein, D.N. Mohr et al., Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study, Arch. Intern. Med. 160 (2000), 809-815.
20. Y. Izumi, Y. Taniuchi, T. Tsuji et al., Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells, Exp. Cell Res. 216 (1995), 215-221.
21. E.A. Jaffe, R.L. Nachman, C.G. Becker et al., Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria, J. Clin. Invest. 52 (1973), 2745-2756.
22. R. Kannagi, Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer, Glycoconj. J. 14 (1997), 577-584.
23. Y.J. Kim, L. Borsig, H.L. Han et al., Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium, Am. J. Pathol. 155 (1999), 461-472.
24. Y.J. Kim, L. Borsig, N.M. Varki et al., P-selectin deficiency attenuates tumor growth and metastasis, Proc. Natl. Acad. Sci. USA 95 (1998), 9325-9330.
25. Y.J. Kim and A. Varki, Perspectives on the significance of altered glycosylation of glycoproteins in cancer, Glycoconj. J. 14 (1997), 569-576.
26. T. Kishimoto, H. Ishikura, C. Kimura et al., Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: the importance of surface sialyl Lewis(a) antigen, Int. J. Cancer 69 (1996), 290-294.
27. J. Kisucka, C.E. Butterfield, D.G. Duda et al., Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage, Proc. Natl. Acad. Sci. USA 103 (2006), 855-860.
28. R. Langley, B. Wines, N. Willoughby et al., The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria, J. Immunol. 174 (2005), 2926-2933.
29. F. Li, P.P. Wilkins, S. Crawley et al., Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P-and E-selectin, J. Biol. Chem. 271 (1996), 3255-3264.
30. G. Mannori, P. Crottet, O. Cecconi et al., Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins, Cancer Res. 55 (1995), 4425-4431.
31. K.L. Moore, K.D. Patel, R.E. Bruehl et al., P-selectin gly-coprotein ligand-1 mediates rolling of human neutrophils on P-selectin, J. Cell Biol. 128 (1995), 661-671.
32. S. Nakamori, M. Kameyama, S. Imaoka et al., Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study, Cancer Res. 53 (1993), 3632-3637.
33. B. Nieswandt, M. Hafner, B. Echtenacher et al., Lysis of tumor cells by natural killer cells in mice is impeded by platelets, Cancer Res. 59 (1999), 1295-1300.
34. C. Prat, J. Bestebroer, C.J. de Haas et al., A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1, J. Immunol. 177 (2006), 8017-8026.
35. G. Raes, G.H. Ghassabeh, L. Brys et al., The metastatic T-cell hybridoma antigen/P-selectin glycoprotein ligand 1 is required for hematogenous metastasis of lymphomas, Int. J. Cancer 121 (2007), 2646-2652.
36. S.H. Rooijakkers, M. Ruyken, A. Roos et al., Immune evasion by a staphylococcal complement inhibitor that acts on C3 con-vertases, Nat. Immunol. 6 (2005), 920-927.
37. D. Sako, K.M. Comess, K.M. Barone et al., A sulfated pep-tide segment at the amino terminus of PSGL-1 is critical for P-selectin binding, Cell 83 (1995), 323-331.
38. D. Schadendorf, J. Heidel, C. Gawlik et al., Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels, J. Natl. Cancer Inst. 87 (1995), 366-371.
39. G. Sinha, Bacterial battalions join war against cancer, Nat. Med. 9 (2003), 1229.
40. K.R. Snapp, H. Ding, K. Atkins et al., A novel P-selectin gly-coprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P-and L-selectin, Blood 91 (1998), 154-164.
41. J.P. Stone and D.D. Wagner, P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer, J. Clin. Invest. 92 (1993), 804-813.
42. S.N. Thomas, F. Zhu, R.L. Schnaar et al., Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E-and L-selectin in shear flow, J. Biol. Chem. 283 (2008), 15647-15655.
43. L. Tu, A. Chen, M.D. Delahunty et al., L-selectin binds to P-selectin glycoprotein ligand-1 on leukocytes: interactions between the lectin, epidermal growth factor, and consensus repeat domains of the selectins determine ligand binding specificity, J. Immunol. 157 (1996), 3995-4004.
44. H.M. Verheul, A.S. Jorna, K. Hoekman et al., Vascular en-dothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets, Blood 96 (2000), 4216-4221.
45. B.W. Weston, K.M. Hiller, J.P. Mayben et al., Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells, Cancer Res. 59 (1999), 2127-2135.
46. I.P. Witz, The involvement of selectins and their ligands in tumor-progression, Immunol. Lett. 104 (2006), 89-93.
47. J.I. Zwicker, B.C. Furie and B. Furie, Cancer-associated thrombosis, Crit. Rev. Oncol. Hematol. 62 (2007), 126-136.